乳果糖保留灌肠治疗肝性脑病疗效观察

来源 :中国实用医药 | 被引量 : 0次 | 上传用户:qncy1232f
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的观察乳果糖保留灌肠治疗肝性脑病的临床疗效。方法 60例肝性脑病患者随机分为两组,在采用西医综合治疗的基础上,治疗组加用乳果糖保留灌肠治疗,对照组采用常规保肝等治疗。结果治疗组总有效率85.0%,明显高于对照组61.7%,两组临床疗效比较及治疗前后血氨变化比较差异均有统计学意义(P<0.05)。结论乳果糖保留灌肠治疗肝性脑病疗效肯定。 Objective To observe the clinical efficacy of lactulose retention enema in the treatment of hepatic encephalopathy. Methods Sixty patients with hepatic encephalopathy were randomly divided into two groups. On the basis of comprehensive treatment with Western medicine, the treatment group was treated with lactulose retention enema, while the control group was treated with conventional hepatoprotective therapy. Results The total effective rate was 85.0% in the treatment group, which was significantly higher than that in the control group (61.7%). There was significant difference in the clinical efficacy between the two groups and the change of blood ammonia before and after treatment (P <0.05). Conclusion lactulose retention enema for the treatment of hepatic encephalopathy certainly.
其他文献
在目的层埋藏极浅地区采用小道距观测系统,在弯线施工中缩小CDP面元的大小,放大地质现象,使地质现象反映更为清晰,在实际施工中取得了较好的地质效果。 In the purpose of t
期刊
期刊
本月全球药品研发进展取得成效的药物有55个,较上月增加8个.进入注册阶段的有26个,较上月减少1个.其中,4个为全球首次注册的药品,在新市场补充注册的为22个.进入注册前阶段的
目的探讨妊娠合并糖尿病的相关危险因素及其logistic分析。方法 2010年8月至2012年8月期间,我院诊治的80例妊娠期糖尿病患者,作为观察组,选取同期80例正常孕妇作为对照组,分
期刊
期刊
期刊
期刊
期刊